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Introduction: Enterocystoplasties are associated to complications. We developed a surgical technique for
bladder autoaugmentation using autologous uterine ﬂap in the rat, to try and improve the post-surgical
evolution.
Methods: 36 female Wistar rats were randomly allocated into following groups: Group 1: Control (n ¼ 12)
for analytical parameters, Group 2: Sham-operation hysterocystorrhaphy (n ¼ 12) and Group 3: Bladder
autoaugmentation with autologous uterine ﬂap (n ¼ 12). Two weeks after surgery ultrasound exami-
nation of the bladder was performed. At 8 weeks and 24 weeks, blood and urine samples were taken.
Post-mortem evaluation was performed and urogenital apparatus removed for gross and microscopic
examination. The statistical analysis was done using the KruskalleWallis and the extension of the
Fisher’s exact test. Signiﬁcance was set at 5% (p < 0.05).
Results: Serum chemistry, blood count and peripheral blood smears, electrolytes and urinary parameters
were all within the normal range for the rat. No abnormal ﬁndings were observed during ultrasound
examination. There was no mortality or other surgical complications. Post-mortem evaluation revealed
no dilation of bladder, uterus or upper urinary tract. Uroliths were not observed. Histology of the aug-
mented area demonstrated an excellent union between the bladder and the protective uterine ﬂap. A
normal urothelial layer was maintained.
Conclusions: The use of autologous uterine ﬂap to perform bladder autoaugmentation in the rat proved
a safe and suitable surgical technique to augment the bladder. The major advantage is the avoidance of
the complications observed in other surgical techniques for bladder augmentation, like enter-
ocystoplasties, where gastrointestinal tract epithelium is incorporated into the urinary tract.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Many surgical techniques have been described to augment the
bladder. Most of them partially substitute the bladder wall with
gastrointestinal segments, however, enterocystoplasties are asso-
ciated to complications,1,2 mostly because of gastrointestinal tissue
being in contact with the urine, such as metabolic and electrolyte
disturbances3 urinary infection,4 urolithiasis5 and malignancy of
the transplanted tissues.6lty of Medicine, University of




ciates Ltd. Published by Elsevier LtUrothelial-lined bladder augmentation is used to create a com-
pliant urinary reservoir, while avoiding the potential complications
of enteric augmentations. It can be accomplished by various
methods.7e9 One of them is autoaugmentation, where a large
diverticular bulge is created by stripping the detrusor with dis-
section at the dome of the bladder, thereby, increasing the storage
capacity of the bladder and reducing storage pressure, without
metabolic disturbance and without the risk of malignancy.10
The resulting bladder capacity and compliance may not always
be preserved because of possible complications, such as perforation
due to thinness of the mucosa in the bulging diverticulum or ad-
hesions to adjacent structures and late ﬁbrosis, which produces
bladder retraction and decrease in bladder volume.11
Demucosalized gastrointestinal segments have been used in
combination with autoaugmentation to provide muscular backingd. All rights reserved.
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urothelial diverticulum. Protection of the bulging mucosa has been
performed with stomach,12 sigmoid,13 small intestine,14 abdominal
rectus muscle,11,15 peritoneum16 and different types of scaffolds.17
However, complications were still described.
Uterocystoplasty has been previously described by Fraser et al.18
They seeded cultured autologous urothelial cells on de-epithelized
uterine tissue for composite bladder augmentation, obtaining
a favourable result. Recently, we introduced a new hyster-
ocystoplasty technique, a novel surgical procedure for bladder
reconstruction using autologous uterine tissue in the rat.19 An
incisionwasmade in the bladderwall, andwas repaired by suturing
the right uterine horn on its middle part and avascular side to the
edges of the cystotomywith continuous stitching, so that the serosa
of the uterine horn stayed in contact with the urine.
Following the same research line, in this study, we aimed to
describe and standardize a possible surgical procedure for bladder
autoaugmentation using a protective vascularized autologous
uterine ﬂap in adult female rats. We assessed its feasibility and
effects, by evaluating different physiological parameters in the
operated rats as well as gross and histopathological ﬁndings.2. Methods
This surgical study was carried out in accordance with the European Commu-
nities Council Directive of 24 November 1986 (86/609/EEC) and with the Spanish
policies regarding the care and use of animals for experimental procedures. All
experimental protocols were reviewed and approved by the Animal Care and Use
Committee of the University of Leon. 36 female Wistar rats with ages ranging from
12 to 14 weeks and mean weight of 254 g were used. All the animals were in good
health and kept in standard habitability conditions.
The animals were randomly allocated into the following surgical groups: sham-
operation hysterocystorrhaphy (n ¼ 12), bladder autoaugmentation using a protec-
tive vascularized autologous uterine ﬂap (n ¼ 12) and control group (n ¼ 12). Serum
chemistry, electrolytes, haematological and urinary parameters, ultrasound exami-
nation and weight control were evaluated in both the control rats and operated
before the surgery was performed.Fig. 1. (a) Sham-operation hysterocystorrhaphy. The right uterine horn was sutured on its
Autoaugmentation with uterine ﬂap. The right uterine horn was identiﬁed and 0.5 cm segme
opened longitudinally along its avascular border and detubularized. A ﬂap of approximate
a defect of approximately 0.5  0.5 cm, without perforating into the mucosal layer. (d) The2.1. Surgical technique
The animals were anaesthetizedwith an i.m. injection ofmedetomidine (0.5mg/
kg), ketamine (75 mg/kg) and midazolam (2 mg/kg).
The abdomen was swabbed with an iodinated solution. It was opened through
a small midline infraumbilical incision of approximately 0.5 cm. The bladder and the
right uterine horn were identiﬁed and full thickness samples were taken, for his-
tological analysis.
In the sham-operation hysterocystorrhaphy the right uterine horn was sutured
on its middle part and avascular border to the bladder dome with continuous
stitching (glyconate, USP 6/0) (Fig. 1a).
In the autoaugmentation group, the autologous uterine ﬂap (Fig. 1b) was pre-
pared by isolating a 0.5 cm segment from the right uterine horn with its vascular
pedicle. The segment was detubularized by a longitudinal incision along its avas-
cular side, obtaining a ﬂap of approximate 0.5  0.5 cm. The bladder was then
prepared by excising carefully from anterior to posterior, the detrusor muscle from
the dome and the anterior surface of the organ (Fig. 1c). A defect of approximately
0.5  0.5 cm was created, without perforating the mucosal layer. The uterine ﬂap
wasmobilized on its vascular pedicle andwas suturedwith continuous stitching and
with the uterine mucosa facing towards the prolapsed vesical mucosa (glyconate,
USP 6/0) to the edges of the bladder defect and over the protruding mucosal
diverticulum to reinforce it (Fig. 1d). The abdominal wall and skin were closed. All
animals had free access to water and food after the surgery.
To assess the feasibility of the surgical technique and its effects, different pa-
rameters were evaluated: general condition of the rats, blood and urinary param-
eters, ultrasound examination, as well as macroscopical and histopathological
ﬁndings.
The general condition of the rats was evaluated by their healthy appearance and
activity, weight control, food and water intake and voiding frequency and pattern.
Two weeks postoperatively, the rats were anaesthetized and an ultrasound exami-
nation of the abdomen was performed to conﬁrm the integrity of the bladder
autoaugmentation. At 8 and at 24 weeks after surgery, 6 animals from each of the 3
groups were anaesthetized and blood and urine samples were taken to perform
serum chemistry, electrolytes, blood count, peripheral blood smears and urinalysis.
The blood tests were aiming to detect any metabolic or electrolyte disturbances, as
well as alterations in the blood count or blood smears, due to chronic inﬂammation
or infection, uraemia, or anaemia. In the urinalysis pH, speciﬁc gravity, urinary
sediment, leucocyturia, proteinuria, haematuria and presence of uroliths were
evaluated.
Only the operated animals were then euthanized for gross and microscopical
examination. The bladders were ﬁxed, sectioned and stained with haematoxylin-
eosin and with Masson’s trichrome for histological evaluation (Fig. 2), to assessmiddle part and avascular border to the bladder dome with continuous stitching. (b)
nt was isolated from the right uterine horn with its vascular pedicle. The segment was
dimensions 0.5  0.5 cm was obtained. (c) The detrusor muscle was excised creating
uterine ﬂap was sutured to the edges of the bladder defect with continuous stitching.
Fig. 2. (a) Panoramic image of autoaugmentation with protective uterine ﬂap showing the suture area (arrow) between the bladder (* black) and uterine ﬂap (* red). There is
excellent survival of the protective uterine ﬂap and it is ﬁrmly attached to the bladder mucosa. Masson’s trichrome stain 10. (b) Bladder autoaugmentation at the junction (arrow)
of the bladder (* black) and uterine ﬂap (* red) in the augmented area. Note a ﬁbrotic collagenous tissue with no signs of inﬂammation above the bladder submucosa, in the area
adjacent to the overlying uterine ﬂap and new muscle ﬁbres. Haematoxylin and eosin stain 150.
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signs of malignancy. The following parameters were evaluated: ﬁbrosis, granulation
tissue, edema, vascular dilation, neovascularization, papilloma, abscesses, micro-
calciﬁcations, granulomas; as well as inﬂammation and proliferation of the lamina
propria and submucosa, muscular and serosa, and atrophy, hyperplasia, squamous
metaplasia and dysplasia of the epithelium. The intensity of the reaction was sub-
jectively graded as low, moderate or strong.
The statistical analysis was performed using the non-parametric Kruskalle
Wallis test for the quantitative data (analytical parameters and weight control)
and the extension of the Fisher’s exact test for the categorical data (ultrasound, post-
mortem and histological examination). In all the statistical tests, signiﬁcance was set
at 5% (p < 0.05) and were performed using a software program (Stata Statistical
Software, Release 10, StataCorp, College Station, TX.).3. Results
In both the autoaugmentation using a protective vascularized
autologous uterine ﬂap and the sham-operation with hyster-
ocystorraphy groups neither mortality nor signiﬁcant complica-
tions were observed. All rats voided spontaneously with normal
frequency and pattern. Two weeks post surgery; an ultrasound
examination of the abdomen was performed, showing no leakage
of urine into the abdomen. There was no dilation of the bladder,
upper urinary tract or uterus. All experimental and control animals
were in good health and the mean weight increased constantly
throughout the 8 or 24week period, from the surgery time until the
time when the animals were euthanized. Systemic parameters
remained within normal levels at all time points. Serum chemistry,
electrolytes, blood count, peripheral blood smears and urinalysis
were all within the normal range for the rat.20 No metabolic or
electrolyte disturbances were found in the serum biochemistry. No
alterations were found in the blood count or blood smears, due to
infection, chronic inﬂammation, anaemia or uraemia. No signs of
infection, inﬂammation or uroliths were observed in the urinalysis.
The post-mortem examination of the abdominal cavity revealed
no dilation of the bladder, uterus or other abdominopelvic organs.
There was one case of adhesions in the sham-operation group to
the rectum. Only two cases were observed in the autoaugmentation
using a protective vascularized autologous uterine ﬂap group, one
to the rectum and one to the omentum, though not statistically
signiﬁcant (p > 0.05). No urinary stones were found in the mac-
roscopic evaluation.
Histological sections of the transition zone between the bladder
and the augmented segment showed excellent survival of theprotective autologous uterine ﬂaps. They were ﬁrmly attached to
the bladder mucosa (Fig. 2a) and no shrinkage of the uterine ﬂap
was observed.
A normal urothelial layer was maintained in both the autoaug-
mentation using a protective vascularized autologous uterine ﬂap
and the sham-operation groups and no evidence of endometrial
mucosa was observed. However, above the bladder submucosa in
the area adjacent to the overlying uterine ﬂap, a ﬁbrotic collage-
nous tissue with no signs of inﬂammation was observed in 3 of the
augmented bladders (p > 0.05). New muscle ﬁbres were found,
suggesting regeneration of new detrusor ﬁbbers in another 3 cases,
although not statistically signiﬁcant (p > 0.05) (Fig. 2b).
In the autoaugmentation using a protective vascularized autol-
ogous uterine ﬂap group, there was no evidence of acute inﬂam-
mation and minimal foci of lymphocytes and plasma cells were
observed. In the sham-operation group few cases (3 of the blad-
ders) of inﬂammation and ﬁbrosis were found (p > 0.05). No signs
of malignancy were observed in any of the operated groups.
4. Discussion
We designed a new experimental surgical technique for bladder
autoaugmentation using a protective vascularized autologous
uterine ﬂap bladder, that was technically feasible and with
a favourable post-surgical evolution.
The use of uterine segments for bladder reconstruction has the
added advantages of the anatomical proximity between the two
organs. It has lower risk of bacterial infection than enter-
ocystoplasties as well as avoiding the potential risks associated
with intestinal anastomosis.18,19 This new autoaugmentation sur-
gical technique using a protective vascularized autologous uterine
ﬂap is less traumatic than conventional enterocystoplasties, as the
surgical incision is much smaller, specially when compared with
gastrocystoplasty, that requires a large midline incision from xi-
phoid to pubis to expose both the stomach and the bladder.21
The main disadvantage we observed when comparing with
hysterocystoplasty,19 was that while the second was very easy to
perform surgically, the autoaugmentation proved to be more dif-
ﬁcult technically, specially the detrusor excision, mainly to avoid
perforation of the newly created diverticulum.
Contrary to observations made by other authors when per-
forming bladder augmentation techniques in animal models,15,22
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formed bladder augmentationwith hysterocystoplasty,19 there was
no mortality either and all the animals showed excellent physical
appearance.
It is known that bladder enterocystoplasties can cause electrolyte,
ﬂuid and acid-base disturbances, as well as alterations in the urinary
parameters.23,24 However, all postoperatively laboratory parameters
controlled throughout this experiment and as well when we per-
formed hysterocystoplasty,19 (serum chemistry, complete blood
count, peripheral blood smears and electrolytes), were within the
physiological range for the rat.20 The development of uroliths is
a typical complication of augmentation cystoplasties.8 It has also
been described in autoaugmentation techniques,15 but calculus for-
mationwasnot observed in anyof theoperated rats of this study. The
absence of urinary stones is an advantage of using uterine tissue for
bladder augmentation. They were not observed in any of the oper-
ated rats when hysterocystoplasty was performed19; similarly, in
composite uterocystoplasty,18 calculus formation was not found.
The appearance of adhesions during the abdominal macroscopic
examination has been described after autoagmentation tech-
niques.16 In this study only two mild cases of adhesions (to the
omentum and rectum) were found in the autoaugmentation group.
Several techniques have been described to reinforce the uro-
thelial diverticulum when performing autoaugmentation, though
not all of them are complication free. Gastro and colocystoplasties
with demucosalized segments and seromuscular enterocystoplasty
coupled with autoaugmentation25,26 have been performed with
satisfactory results. Removal of the submucosa and muscularis
mucosa in colocystoplasties has been recommended to avoid
mucosal regrowth, but demucosalization proves difﬁcult and in-
creases surgery time.22,27 In rats mucous cysts and dilated glan-
dular crypts have been described, because the preserved
urothelium covers the glands in the thickness of the submucosa,
not allowing its emptying and therefore accumulating as mucoce-
les.22When autoaugmentation omentocystoplasty was performed
in a sheep model, the urothelial lining was preserved, but con-
tinued inﬂammation, ﬁbrosis and heterotopic calciﬁcation were
seen within the subepithelial tissues associated with a failure to
achieve enlargement of the bladder.28 Peritoneocystoplasty16
makes no improvement in bladder capacity. Examination of the
resected bladders conﬁrmed contraction in the area of the peri-
toneal ﬂap, ﬁbrosis and scar formation, though no signiﬁcant in-
ﬂammatory inﬁltrate was apparent.
Bladder autoaugmentation with rectus muscle backing has been
described in an animal15 and in a human model.11 It is completely
extraperitoneal and minimally invasive, with good results. Dis-
advantage of the technique is limited postoperative expansion of
the new augmented segment of the bladder.15 Scaffolds of poly-
glycolic acid mesh; small intestinal submucosa17 and collagen
layers22 have been used to reinforce the prolapsed mucosa. Only the
polyglycolic acid mesh seeded with autologous bladder smooth
muscle cells group showed a signiﬁcant increase in bladder capacity.
The other groups had marked graft shrinkage and ﬁbrosis.17,22
In the present study, the gross and histological evaluation
showed excellent survival of the uterine ﬂaps, with no evidence of
separation of the native urothelium from the ﬂaps or of ﬁbrosis of
the uterine ﬂap.
Histology revealed that the bladder mucosa had a normal
appearing urothelium throughout and that there was no evidence
of chronic inﬂammation or scar in the submucosal layer adjacent to
the overlying uterine ﬂap. Contrarily, Fraser et al.18 describe in-
ﬂammatory cells in every bladder augmented with uterine grafts,
even in the segments further away from the reconstructed area.
When performing hysterocystoplasty,19 ﬁbrosis, urothelial
papillomas, microcalciﬁcations and granulomas were observed inthe transition zone between the bladder and the uterine horn, in
some of the operated animals; as well as inﬂammation of the
lamina propria of the bladder and of the muscular layer of the
uterine horn. All of these ﬁndings though, were not statistically
signiﬁcant. Complete urothelial epithelisation over the serosa of
the uterine horn used for the bladder augmentation was observed
in 72.2% of the rats that underwent hysterocystoplasty, providing
an adequate urothelial lining.
In the autoaugmented bladders using a protective vascularized
autologous uterine ﬂap we observed additional muscle ﬁbres above
the muscularis mucosa in three of the experimental bladders. This
ﬁnding suggests new detrusor ﬁbber differentiation. In this sense
detrusor bundles in the native bladder submucosa were also
described in a model of autoaugmentation gastrocystoplasty.12
In conclusion, the major advantage of autoaugmentation using
a protective vascularized autologous uterine ﬂap is the avoidance of
the typical complications of incorporating gastrointestinal tract
epithelium into the urinary tract. The augmented bladders showed
good function with normal micturition few hours after the surgery.
All laboratory parameters analysed were within the normal phys-
iological range for the rat. No ﬂap shrinkage or bladder wall scar-
ring was observed and histological examination demonstrated
minimal ﬁbrosis and inﬂammation in the augmented area. The
urothelial coverage was normal throughout the augmented blad-
der. The results obtained of this new surgical method suggest that
this technique is safe in a rat model. The autoaugmented bladder
using a protective vascularized autologous uterine ﬂap demon-
strated good viability and integrity of the uterine ﬂap and of the
augmented bladder.
Ethical approval
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